Successful Treatment of a Patient with Brentuximab Vedotin-Refractory ALK-Negative Anaplastic Large Cell Lymphoma with Romidepsin

We present the case of a 78-year-old male patient who was diagnosed with anaplastic lymphoma kinase (ALK)-negative, CC chemokine receptor 4 (CCR4)-negative, and CD30-positive anaplastic large cell lymphoma (ALCL). The patient had a past medical history of adult T-cell leukemia/lymphoma and colon can...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Tatsuro Jo, Takahiro Sakai, Kaori Matsuzaka, Haruna Shioya, Hiroo Tominaga, Yohei Kaneko, Shizuka Hayashi, Masatoshi Matsuo, Jun Taguchi, Kuniko Abe, Kazuto Shigematsu
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Karger Publishers 2020-11-01
Rangatū:	Case Reports in Oncology
Ngā marau:	adult t-cell leukemia/lymphoma anaplastic large cell lymphoma colon cancer cytotoxic t lymphocyte human t-lymphotropic virus type 1 tax romidepsin
Urunga tuihono:	https://www.karger.com/Article/FullText/511111
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!